Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 27, 2023

SELL
$0.12 - $0.3 $3,253 - $8,134
-27,114 Reduced 64.86%
14,689 $1,000
Q4 2022

Feb 02, 2023

SELL
$0.09 - $0.16 $37,568 - $66,787
-417,423 Reduced 90.9%
41,803 $4,000
Q3 2022

Nov 04, 2022

BUY
$0.14 - $1.07 $57,499 - $439,461
410,712 Added 846.58%
459,226 $69,000
Q2 2022

Aug 03, 2022

BUY
$0.88 - $1.73 $42,692 - $83,929
48,514 New
48,514 $42,000

Others Institutions Holding VTGN

About VistaGen Therapeutics, Inc.


  • Ticker VTGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 206,836,000
  • Market Cap $720M
  • Description
  • VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...
More about VTGN
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.